CCXI logo

ChemoCentryx (CCXI) EBITDA

Annual EBITDA

-$125.92 M
-$74.00 M-142.55%

December 31, 2021

Summary

Performance

1-Year Change

-142.55%

3-Year Change

-247.56%

5-Year Change

-788.81%

15-Year Change

-788.81%

CCXI EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$18.28 M
CCXI annual EBITDA is currently -788.81% below its historical high of $18.28 million

3-Year Low

-$125.92 M
CCXI annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
CCXI previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
CCXI next annual earnings announcement has not yet been scheduled

OtherCCXIprofitabilitymetrics:

Annual Revenue

$31.90 M
CCXI annual revenue is $31.90 million

Annual Net Income

-$131.75 M
CCXI annual net profit is -$131.75 million

Annual EBIT

-$129.06 M
CCXI annual earnings before interest & taxes is -$129.06 million

Annual EPS

-$1.89
CCXI annual earnings per share is -$1.89

Quarterly EBITDA

-$30.04 M
+$6.95 M+18.79%

June 30, 2022

Summary

Performance

3-Month Change

+18.79%

1-Year Change

+19.91%

3-Year Change

-111.79%

5-Year Change

-228.86%

CCXI Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$39.77 M
CCXI quarterly EBITDA is currently -175.54% below its historical high of $39.77 million

3-Year Low

-$38.87 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CCXI previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CCXI next earnings announcement has not yet been scheduled

OtherCCXIprofitabilitymetrics:

Quarterly Revenue

$11.76 M
CCXI quarterly revenue is $11.76 million

Quarterly Net Income

-$31.65 M
CCXI quarterly net profit is -$31.65 million

Quarterly EBIT

-$31.07 M
CCXI quarterly earnings before interest & taxes is -$31.07 million

Quarterly EPS

-$0.44
CCXI quarterly earnings per share is -$0.44

TTM EBITDA

-$126.54 M
+$7.47 M+5.57%

June 30, 2022

Summary

Performance

3-Month Change

+5.57%

1-Year Change

-6.85%

3-Year Change

-141.47%

5-Year Change

-141.47%

CCXI TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$18.28 M
CCXI TTM EBITDA is currently -792.19% below its historical high of $18.28 million

3-Year Low

-$134.01 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CCXI previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CCXI next earnings announcement has not yet been scheduled

OtherCCXIprofitabilitymetrics:

TTM Revenue

$37.20 M
CCXI TTM revenue is $37.20 million

TTM Net Income

-$133.09 M
CCXI TTM net profit is -$133.09 million

TTM EBIT

-$130.60 M
CCXI TTM earnings before interest & taxes is -$130.60 million

TTM EPS

-$1.89
CCXI TTM earnings per share is -$1.89

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$125.92 M
CCXI annual EBITDA is -$125.92 million

Annual Net Income

-$131.75 M
CCXI annual net profit is -$131.75 million

Annual Interest Expense

$2.69 M
CCXI annual interest expense is $2.69 million

Annual Income Tax

-
CCXI annual income tax value is unknown

Annual D&A

$3.14 M
CCXI annual depreciation & amortization is $3.14 million

CCXI EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-142.6%+19.9%-6.8%
3 y3 years-247.6%-111.8%-141.5%
5 y5 years-788.8%-228.9%-141.5%

CCXI EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+29.4%+0.5%+5.9%
5 y5-year+142.5%at low-242.4%+29.4%+367.0%+5.9%
alltimeall time-788.8%at low-175.5%+29.4%-792.2%+5.9%

ChemoCentryx EBITDA History

DateAnnualQuarterlyTTM
Jun 2022
-
-$30.04 M(-18.8%)
-$126.54 M(-5.6%)
Mar 2022
-
-$36.99 M(-4.8%)
-$134.01 M(+6.4%)
Dec 2021
-$125.92 M(+142.5%)
-$38.87 M(+88.4%)
-$125.92 M(+8.7%)
Sep 2021
-
-$20.64 M(-45.0%)
-$115.83 M(-2.2%)
Jun 2021
-
-$37.51 M(+29.8%)
-$118.43 M(+98.0%)
Mar 2021
-
-$28.91 M(+0.4%)
-$59.83 M(+15.2%)
Dec 2020
-$51.92 M(-1.7%)
-$28.78 M(+23.9%)
-$51.92 M(+36.6%)
Sep 2020
-
-$23.23 M(-210.1%)
-$38.01 M(+40.3%)
Jun 2020
-
$21.09 M(-200.5%)
-$27.09 M(-56.6%)
Mar 2020
-
-$21.00 M(+41.2%)
-$62.37 M(+19.0%)
Dec 2019
-$52.79 M(+45.7%)
-$14.87 M(+20.7%)
-$52.40 M(+9.8%)
Sep 2019
-
-$12.32 M(-13.1%)
-$47.73 M(+4.4%)
Jun 2019
-
-$14.18 M(+28.6%)
-$45.73 M(+20.0%)
Mar 2019
-
-$11.03 M(+8.1%)
-$38.13 M(+5.2%)
Dec 2018
-$36.23 M(-298.2%)
-$10.20 M(-1.2%)
-$36.23 M(-363.8%)
Sep 2018
-
-$10.32 M(+57.0%)
$13.73 M(-22.0%)
Jun 2018
-
-$6.58 M(-28.0%)
$17.61 M(+17.0%)
Mar 2018
-
-$9.13 M(-123.0%)
$15.05 M(-17.7%)
Dec 2017
$18.28 M(-146.1%)
$39.77 M(-716.3%)
$18.28 M(-164.0%)
Sep 2017
-
-$6.45 M(-29.4%)
-$28.56 M(-2.7%)
Jun 2017
-
-$9.13 M(+54.9%)
-$29.35 M(-3.0%)
Mar 2017
-
-$5.90 M(-16.6%)
-$30.27 M(-23.6%)
Dec 2016
-$39.62 M
-$7.07 M(-2.4%)
-$39.62 M(-9.4%)
Sep 2016
-
-$7.24 M(-28.0%)
-$43.72 M(-9.1%)
Jun 2016
-
-$10.06 M(-34.0%)
-$48.10 M(-4.0%)
DateAnnualQuarterlyTTM
Mar 2016
-
-$15.24 M(+36.4%)
-$50.09 M(+7.0%)
Dec 2015
-$46.83 M(+1.0%)
-$11.17 M(-3.9%)
-$46.83 M(-1.9%)
Sep 2015
-
-$11.63 M(-3.5%)
-$47.71 M(+1.7%)
Jun 2015
-
-$12.05 M(+0.6%)
-$46.89 M(-0.2%)
Mar 2015
-
-$11.98 M(-0.7%)
-$46.97 M(+1.3%)
Dec 2014
-$46.36 M(+21.9%)
-$12.06 M(+11.6%)
-$46.36 M(+6.1%)
Sep 2014
-
-$10.81 M(-10.8%)
-$43.68 M(+3.6%)
Jun 2014
-
-$12.12 M(+6.6%)
-$42.15 M(+7.0%)
Mar 2014
-
-$11.37 M(+21.2%)
-$39.38 M(+3.5%)
Dec 2013
-$38.04 M(-1.2%)
-$9.38 M(+1.1%)
-$38.04 M(-0.7%)
Sep 2013
-
-$9.28 M(-0.8%)
-$38.30 M(-1.7%)
Jun 2013
-
-$9.35 M(-6.8%)
-$38.98 M(-3.4%)
Mar 2013
-
-$10.03 M(+4.1%)
-$40.35 M(+4.8%)
Dec 2012
-$38.51 M(+1130.6%)
-$9.64 M(-3.1%)
-$38.51 M(+289.7%)
Sep 2012
-
-$9.95 M(-7.2%)
-$9.88 M(+19.3%)
Jun 2012
-
-$10.72 M(+30.9%)
-$8.28 M(+57.8%)
Mar 2012
-
-$8.19 M(-143.2%)
-$5.25 M(+67.7%)
Dec 2011
-$3.13 M(+28.9%)
$18.98 M(-327.3%)
-$3.13 M(-81.4%)
Sep 2011
-
-$8.35 M(+8.7%)
-$16.83 M(+2.8%)
Jun 2011
-
-$7.69 M(+26.6%)
-$16.38 M(+88.4%)
Mar 2011
-
-$6.07 M(-215.1%)
-$8.69 M(+231.8%)
Dec 2010
-$2.43 M(-114.5%)
$5.28 M(-166.8%)
-$2.62 M(-66.8%)
Sep 2010
-
-$7.90 M
-$7.90 M
Dec 2009
$16.70 M(-194.6%)
-
-
Dec 2008
-$17.66 M
-
-

FAQ

  • What is ChemoCentryx annual EBITDA?
  • What is the all time high annual EBITDA for ChemoCentryx?
  • What is ChemoCentryx annual EBITDA year-on-year change?
  • What is ChemoCentryx quarterly EBITDA?
  • What is the all time high quarterly EBITDA for ChemoCentryx?
  • What is ChemoCentryx quarterly EBITDA year-on-year change?
  • What is ChemoCentryx TTM EBITDA?
  • What is the all time high TTM EBITDA for ChemoCentryx?
  • What is ChemoCentryx TTM EBITDA year-on-year change?

What is ChemoCentryx annual EBITDA?

The current annual EBITDA of CCXI is -$125.92 M

What is the all time high annual EBITDA for ChemoCentryx?

ChemoCentryx all-time high annual EBITDA is $18.28 M

What is ChemoCentryx annual EBITDA year-on-year change?

Over the past year, CCXI annual EBITDA has changed by -$74.00 M (-142.55%)

What is ChemoCentryx quarterly EBITDA?

The current quarterly EBITDA of CCXI is -$30.04 M

What is the all time high quarterly EBITDA for ChemoCentryx?

ChemoCentryx all-time high quarterly EBITDA is $39.77 M

What is ChemoCentryx quarterly EBITDA year-on-year change?

Over the past year, CCXI quarterly EBITDA has changed by +$7.47 M (+19.91%)

What is ChemoCentryx TTM EBITDA?

The current TTM EBITDA of CCXI is -$126.54 M

What is the all time high TTM EBITDA for ChemoCentryx?

ChemoCentryx all-time high TTM EBITDA is $18.28 M

What is ChemoCentryx TTM EBITDA year-on-year change?

Over the past year, CCXI TTM EBITDA has changed by -$8.11 M (-6.85%)